A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism

Contraception

Volumn 84, Issue 5, 2011, Pages 508-511

  Oner, Gokalp ^a   Muderris, Iptisam Ipek ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Combined oral contraceptive; Drospirenone; Ethinyl estradiol; Hirsutism

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FERRIMAN GALLWEY SCORE; HIRSUTISM; HUMAN; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL;

ADULT; ALDOSTERONE ANTAGONISTS; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; FEMALE; HIRSUTISM; HUMANS; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80054880000     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.03.002     Document Type: Article

References (23)

1. R.L. Barbieri Hyperandrogenic disorders Clin Obstet Gynecol 33 1990 640 654 (Pubitemid 20321228)
2. E.S. Knochenhauer, and R. Azziz Advances in the diagnosis and treatment of the hirsute patient Curr Opin Obstet Gynecol 7 1995 344 350
3. O. Gregoriou, K. Papadias, and S. Konidaris Treatment of hirsutism with combined pill containing drospirenone Gynecol Endocrinol 24 2008 220 223 (Pubitemid 351481781)
4. K.S. Oláh The modern management of hirsutism Rev Gynaecol Practise 4 2004 211 220 (Pubitemid 40017157)
5. A. Murphy, C.S. Cropp, B.S. Smith, R.T. Burkman, and H.A. Zacur Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women Fertil Steril 53 1990 35 39 (Pubitemid 20041312)
6. R. Azziz The evaluation and management of hirsutism Obstet Gynecol 101 2003 995 1007 (Pubitemid 36561267)
7. R. Krattenmacher Drospirenone: pharmacology and pharmacokinetics of unique progestogen Contraception 62 2000 29 38
8. W.A. van Vloten, C.W. van Haselen, E.J. van Zuuren, C. Gerlinger, and R. Heithecker The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea Cutis 69 2002 2 15
9. H. Thorneycroft, H. Gollnick, and I. Schellschmidt Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment Cutis 74 2004 123 130 (Pubitemid 39207746)
10. C. Batukan, and I.I. Muderris Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism Fertil Steril 85 2006 436 440 (Pubitemid 43170919)
11. A. Kriplani, A.J. Periyasamy, N. Agarwal, V. Kulshrestha, A. Kumar, and A.C. Ammini Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome Contraception 82 2010 139 146
12. G. Bachmann, P.J. Sulak, C. Sampson-Landers, N. Benda, and J. Marr Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone Contraception 70 2004 191 198 (Pubitemid 39119980)
13. T.B. Pearlstein, G.A. Bachmann, H.A. Zacur, and K.A. Yonkers Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation Contraception 72 2005 414 421 (Pubitemid 41676830)
14. W. Koltun, A.W. Lucky, and D. Thiboutot Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial Contraception 77 2008 249 256
15. R. Homburg What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome Hum Reprod 17 2002 2495 2499 (Pubitemid 35174093)
16. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830 (Pubitemid 11046650)
17. H. Blode, W. Wuttke, W. Loock, G. Röll, and R. Heithecker A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers Eur J Contracept Reprod Health Care 5 2000 256 264 (Pubitemid 32165464)
18. M. Guido, D. Romualdi, and M. Giuliani Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study J Clin Endocrinol Metab 89 2004 2817 2823 (Pubitemid 38766371)
19. P.J. Sulak, T.J. Kuehl, M. Ortiz, and B.L. Shull Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms Am J Obstet Gynecol 186 2002 1142 1149 (Pubitemid 34665050)
20. S.J. Keam, and A.J. Wagstaff Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive Treat Endocrinol 2 2003 49 70 (Pubitemid 37051602)
21. C. Batukan, I.I. Muderris, B. Ozcelik, and A. Ozturk Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism Gynecol Endocrinol 23 2007 38 44
22. V. Bruni Bresciani Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen Minerva Ginecol 62 2010 261 266
23. M. Cremer, S. Phan-Weston, and A. Jacobs Recent innovations in oral contraception Semin Reprod Med 28 2010 140 146